Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MedMira Inc
V.MIR
Alternate Symbol(s):
MMIRF
Healthcare
Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid...
diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MIR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Jan 15, 2024 11:32am
Sedar
?
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Comment by
goldyhawk
on Jan 12, 2024 2:07pm
RE:Who. Is number TWO
Medmira needs to move to China Canada loves tests from China
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Jan 11, 2024 10:11am
MEDMIRA IS RESPONSIBLE FOR MANY
Intriguing adventures into a new world of testing Miroq Medduo etc etc as well as many associates in business , finance,education , government, medicine etc etc
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Jan 10, 2024 2:07pm
Who. Is number TWO
In 2023 Medmira said they had 2 new established distributors for the U..S. and Latin America
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Jan 10, 2024 12:16pm
Anyone apply for TRICH. Test patent yet
?
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Comment by
goldyhawk
on Jan 09, 2024 1:18pm
RE:RE:5 minute test tackles silent std epidemic
MIRIAD should be myriad —-I know —/////. Couldn’t resist
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Comment by
goldyhawk
on Jan 09, 2024 1:13pm
RE:5 minute test tackles silent std epidemic
It seems Medmira started working on the commercialization of Aldretes concept of detecting this sti a year ago while Medmira is able to get test results rapidly it also is try to help shorten
...more
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Jan 09, 2024 9:54am
5 minute test tackles silent std epidemic
Search that title interesting
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Jan 05, 2024 10:31am
Are MEDMIRA SYPHILIS TRIALS COMPLETED
?????
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Comment by
goldyhawk
on Dec 30, 2023 10:05am
RE:did Medmira submit SYPHILIS TEST to HC yet
NO NOT SUBMITTED
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 29, 2023 11:01pm
New Press Release - MedMira Reports First Quarter Results FY2024
HALIFAX, NS / ACCESSWIRE / December 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2023.Corporate updateDuring Q1 FY2024, MedMira continued its focus on its regulatory and clinical trial work for a number of products, while...
read article.
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Dec 24, 2023 11:42am
did Medmira submit SYPHILIS TEST to HC yet
Or are the studies completed yet ?????
(11)
•••
SEMY
X
View Profile
View Bullboard History
Post by
SEMY
on Dec 19, 2023 4:54pm
Looking Like Bologna for Xmas
FML!
(7)
•••
goldyhawk
X
View Profile
View Bullboard History
Post by
goldyhawk
on Dec 18, 2023 1:06pm
This week perfect timing to report
A good set of quarterly FINANCIALS ——-or—- A HALT WOULD BE GOOD
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >